【ChiCTR2500111062】Maintenance Venetoclax Based Therapy Post Complete Remission In AML Fit Patients
ChiCTR2500111062
尚未开始
/
/
/
2025-10-24
/
/
acute myeloid leukemia
Maintenance Venetoclax Based Therapy Post Complete Remission In AML Fit Patients
Maintenance Venetoclax Based Therapy Post Complete Remission In AML Fit Patients
The aim of this study is to explore the efficacy of maintenance SC cytarabine + venetoclax therapy as regard disease free survival (DFS) in AML fit patients who achieved CR after highly aggressive chemotherapy as bridge for BMT or if BMT will be delayed or canceled due to any other reason.
随机平行对照
Ⅲ期
The randomization sequence will be generated by an independent statistician using a computer-based random number generator. Patients will be allocated in a 1:1 ratio to receive Venetoclax maintenance or placebo
Investigators and participants will remain blinded to the treatment allocation, ensuring that neither the enrollment process nor subsequent assessments are biased.
Sohag university
/
40
/
2025-11-01
2027-10-10
/
1-Age : 18 - 60 years . 2-Patients who are not eligible for immediate bone marrow transplantation. 3-Newly diagnosed AML patients who attained CR after 1st line. 4-Refractory / recurrant AML patients .；
请登录查看1-Patients not on CR . 2-Age : younger than 18 or older than 60 3-Patients not eligible for bone marrow transplation；
请登录查看Sohag university
/
Sohag university的其他临床试验
- Evaluation of blood and nerve functions among household contacts of leprosy patients in Sohag governorate
- Maintenance Venetoclax Based Therapy Post Complete Remission In AML Fit Patients
- A Comparative study between Induction Chemotherapy Followed by Concurrent Chemoradiation versus Concurrent Chemoradiation in the Management of Locally Advanced Uterine Cervical Cancer
Sohag university的其他临床试验
- Evaluation of blood and nerve functions among household contacts of leprosy patients in Sohag governorate
- Maintenance Venetoclax Based Therapy Post Complete Remission In AML Fit Patients
- A Comparative study between Induction Chemotherapy Followed by Concurrent Chemoradiation versus Concurrent Chemoradiation in the Management of Locally Advanced Uterine Cervical Cancer
- THE OUTCOME OF MULTIDISCIPLINARY MANAGEMENT OF CAROTID BODY TUMORS: A RETROSPECTIVE COHORT STUDY
最新临床资讯
-
大鹏制药临床III期成功
新药说2026-08-13
-
新一代 EGFR-TKI 首个全球 III 期成功
丁香园 Insight 数据库2026-08-13
-
体外诊断原料网2026-08-13
-
佰傲谷BioValley2026-08-13
-
久有基金2026-08-13
-
重庆宸安生物2026-08-13
-
UmabsDB2026-08-13
-
希格生科2026-08-13
-
bioSeedin柏思荟2026-08-13
-
智飞智讯2026-08-13
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 20 8
-
摩熵咨询 34 27
-
摩熵咨询 20 5
-
颁布机构：四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构：国家医保局 2026-07-31
-
颁布机构：国家药品审评中心（CDE） 2026-07-24
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 35 36
-
摩熵咨询 28 38
-
摩熵咨询 34 18
-
颁布机构：国家市场监督管理总局 2026-08-10
-
颁布机构：国家市场监督管理总局 2026-05-29
-
颁布机构：国家市场监督管理总局 2026-05-29